These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32944928)

  • 1. Parathyroid hormone resistance from severe hypomagnesaemia caused by cisplatin.
    Puchalski AR; Hodge MB
    Endokrynol Pol; 2020; 71(6):577-578. PubMed ID: 32944928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizures in a patient with disseminated testicular cancer due to cisplatin-induced hypomagnesaemia.
    van de Loosdrecht AA; Gietema JA; van der Graaf WT
    Acta Oncol; 2000; 39(2):239-40. PubMed ID: 10859019
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional hypoparathyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency.
    Rude RK; Oldham SB; Singer FR
    Clin Endocrinol (Oxf); 1976 May; 5(3):209-24. PubMed ID: 182417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium depletion in patients receiving cisplatin-based chemotherapy.
    Hodgkinson E; Neville-Webbe HL; Coleman RE
    Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):710-8. PubMed ID: 17100159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
    Doornebal J; Bijlsma R; Brouwer RM
    Ned Tijdschr Geneeskd; 2009; 153():A711. PubMed ID: 19930736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomagnesaemia in oncologic patients: to treat or not to treat?
    Wolf FI; Trapani V; Cittadini A; Maier JA
    Magnes Res; 2009 Mar; 22(1):5-9. PubMed ID: 19441269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for parathyroid failure in magnesium deficiency.
    Anast CS; Mohs JM; Kaplan SL; Burns TW
    Science; 1972 Aug; 177(4049):606-8. PubMed ID: 5049304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on the importance of monitoring serum magnesium in advanced disease patients.
    Centeno C; López Saca JM
    Curr Opin Support Palliat Care; 2013 Dec; 7(4):396-405. PubMed ID: 24126921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypocalcemia induced by cisplatin. Inappropriate parathyroid response due to hypomagnesemia].
    Chauffert B; Chevet D; Chantereau MJ; Tanter Y; Charffedine K; Lorcerie B
    Presse Med; 1991 Aug 31-Sep 7; 20(27):1288-9. PubMed ID: 1832768
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Symptomatic hypomagnesaemia after parathyroidectomy.
    Sutton RA
    Br Med J; 1973 Oct; 4(5884):112. PubMed ID: 4745339
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of intervention to prevent hypomagnesemia in cervical cancer patients receiving combination cisplatin and radiation treatment.
    Hunter RJ; Pace MB; Burns KA; Burke CC; Gonzales DA; Webb NF; Levenback CF; Jhingran A; Parker C; Munsell MF; Smith JA
    Support Care Cancer; 2009 Sep; 17(9):1195-201. PubMed ID: 19172305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potassium replacement associated with the development of tetany in a patient with hypomagnesaemia.
    Cohen L
    Magnes Res; 1993 Mar; 6(1):43-5. PubMed ID: 8369199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent hypomagnesaemia following parathyroid surgery, hypermagnesuria as a possible cause.
    Tambyah PA; Rauff A; Lee KO
    Ann Acad Med Singap; 1990 Jul; 19(4):536-9. PubMed ID: 2221815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid function during chronic magnesium deficiency.
    Connor TB; Toskes P; Mahaffey J; Martin LG; Williams JB; Walser M
    Johns Hopkins Med J; 1972 Aug; 131(2):100-17. PubMed ID: 5050732
    [No Abstract]   [Full Text] [Related]  

  • 15. The unexpected burden of hypomagnesaemia in gynae-oncology chemotherapy clinics.
    Herbert C; Cornes P
    Clin Oncol (R Coll Radiol); 2011 Jun; 23(5):373-4. PubMed ID: 21296563
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomised study to determine whether routine intravenous magnesium supplements are necessary in patients receiving cisplatin chemotherapy with continuous infusion 5-fluorouracil.
    Evans TR; Harper CL; Beveridge IG; Wastnage R; Mansi JL
    Eur J Cancer; 1995; 31A(2):174-8. PubMed ID: 7718321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorders of magnesium/calcium metabolism related to cisplatin therapy].
    Jensen JB; Charles P; Sell A
    Ugeskr Laeger; 1986 Dec; 148(50):3374-5. PubMed ID: 3810942
    [No Abstract]   [Full Text] [Related]  

  • 18. Impaired release of parathyroid hormone in magnesium deficiency.
    Anast CS; Winnacker JL; Forte LR; Burns TW
    J Clin Endocrinol Metab; 1976 Apr; 42(4):707-17. PubMed ID: 177448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetany in children treated with cisplatinum.
    Welch RJ; Pearson AD; Craft AW
    Pediatr Hematol Oncol; 1987; 4(2):167-70. PubMed ID: 3152923
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuous magnesium infusions in the management of systemic anti-cancer therapy-related hypomagnesaemia.
    Mateo-Carrasco H; Kostrzynski O; Ndefo O; Stapley S; Davies E; Agarwal R
    Int J Clin Pharm; 2017 Aug; 39(4):657-661. PubMed ID: 28444546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.